Insilico Medicine

🔇 Science42: #DORA New Powerful Features below! We’re excited to announce the release of DORA 1.3.0, packed with innovative features and enhancements that will significantly improve your #research and document generation experience. Here’s a look at what’s new: 1. Enhanced Transparency in #DocumentGeneration  Curious about how DORA creates your documents? With this release, you’ll have real-time visibility into DORA’s step-by-step process: Track progress for each section and see which data-retrieving agents are being used. Experience a dynamic, live-updating interface during document generation. Explore generation logs within the final document for full transparency. This builds trust by showing how your inputs shape the final product. 2. Web Search Tool for Seamless Information Integration DORA now integrates external website data directly into your documents! The Websearch Agent enhances your research by comparing DORA’s data with #PubMed/PMC knowledge, adding valuable web-based references. Links are automatically included in your #bibliography and export files. All references in the document are clickable, enhancing traceability and transparency throughout your research. 3. Editable Research Plans Gain full control over your research process with editable research plans: Now, you can customize and adjust your research instructions for each document, ensuring a personalized and efficient workflow. 4. Custom #Bibliography Fixes We’ve made some small impactful improvements: Button placements and alignments have been optimized for smaller screens. DORA’s Publication Agent Searcher now pulls more references from PubMed/PMC, complementing your custom bibliography for richer document content. 5. Template Filtering for Easier Navigation  Navigating your templates is now easier with our new #filtering logic 6. Document Titles and Export Updates  Say goodbye to “Untitled Document”—all new documents now automatically receive titles. Export improvements ensure that disclaimers appear only on the cover page for cleaner, more professional Word documents. We hope these powerful new features enhance your DORA experience. Thank you for your continued feedback, and happy researching with DORA! #newrelease #newfeatures #DORAupdates #multiagents #AIagents

Happening today! ⏰ Hear from Alex Zhavoronkov, PhD, as he will lead a workshop on End-to-End #DrugDiscovery and Development using #GenerativeAI, hosted by the (National Center for Advancing Translational Sciences (NCATS) and The National Institutes of Health. Register here: https://lnkd.in/ePn-APeG

📅 Mark your calendars for Pharma.ai Webinar week, coming next month! Secure your registration today: https://lnkd.in/e2Vy4Euh

Thank you to for your continued feedback, Alexey Strygin! Check out #DORA for yourself here: https://pharma.ai/dora

The Insilico Medicine team heads to BIO Europe on November 4-6, in Stockholm, Sweden. BIO Europe brings over 5,500 attendees, representing more than 2,800 companies and over 60 countries across the #lifescience ecosystem. Stay tuned for more event updates, and be sure to book a meeting with our team onsite. Visit https://bit.ly/4fgBEvR for more information. Michelle Chen Jan Szollos, MBA Daria Bou Dargham #BIOEurope #Stockholm #EuropeanBiotech #LifeSciences #PartneringEvents

Check out this insightful article by Life Science Leader on how AI is shaping the future of healthcare, featuring insights from Insilico Medicine and other industry leaders. 🚀 Read more: https://lnkd.in/eRfbqWdH #AIinHealthcare #DrugDevelopment #BiotechInnovation #InsilicoMedicine #AI #LifeSciences #PharmaTech

#TEAD is a truly exciting area in #drugdiscovery because not only does it offer a monotherapy approach for highly unmet medical needs like mesothelioma, but it also holds great potential for combination therapies, which could create profound benefits for patients in need. Join us as Keith Mikule, our VP of business development provides a quick glance into this promising target and our AI-generated Pan TEAD inhibitor, ISM6331.

👏 Thank you, SAE Media Group , for inviting Petrina Kamya, Ph.D. to Co-Chair the Inaugural AI Drug Discovery Summit with Christos A. Nicolaou and for the opportunity to provide the keynote on Day 2. Key takeaways: -Customizable GenAI tools for Target ID, such as PandaOmics, allow researchers to uncover novel targets for their disease of interest and grasp the underlying mechanisms from multiple sources of evidence, including publications, grants, multi-omics and financial data. -When paired with customizable platforms such as Chemistry42's ADMET models and Alchemistry, researchers can rapidly validate their target-disease hypothesis at a cost in record time and bolster their pipelines with programs that are more likely to succeed.

Coming up next week 📅 Join Alex Zhavoronkov at The aramco Entrepreneurship Summit, and the FII Institute events, where innovators will be driving progress in healthcare, #AI, sustainability and much more.

📽 While DORA is a complex multi-model system that operates various research tools, its primary task is to help #researchers and busy #biomedical professionals draft a variety of documents and research papers. Researchers need tools that not only accelerate the writing process but also automate and streamline the search for scientific references and their incorporation into draft documents. DORA addresses these needs, enabling users to focus more on their research and less on time-intensive writing tasks. Check out the latest video on how to generate a research paper with pre-existing results below 👇 #DORA #ResearchPaper #DocumentGeneration #WritingTasks